In B cell lymphoma, aberrancy of EZH2 has been associated with EZH2 tyrosine 641 (Y641N) mutation seen in ~22% of diffuse large B-cell lymphoma (DLBCL) and 7% of follicular lymphoma (FL) patients (15–17). This evidence concerns the gene EZH2 and follicular lymphoma.